Kenya - inglese - Pharmacy and Poisons Board

mylan laboratories limited c/o surgilinks ltd mylan laboratories limited r&d center plot no. - abacavir sulfate usp - modified-release tablet - abacavir sulfate usp eq. to abacavir 30mg - antivirals for systemic use:

Kenya - inglese - Pharmacy and Poisons Board

mylan laboratories limited c/o surgilinks ltd r & d centre plot no. 34-a anrich industrial - abacavir sulfate usp - modified-release tablet - abacavir sulfate usp equivalent to abacavir 60 mg - antivirals for systemic use:

Kenya - inglese - Pharmacy and Poisons Board

cipla ltd cipla house, peninsula business park, ganpatrao - abacavir sulfate lamivudine lopinavir ritonavir - capsule - abacavir sulfate usp equivalent to… - antivirals for systemic use: combinations of

Canada - inglese - Health Canada

apotex inc - abacavir (abacavir sulfate); lamivudine - tablet - 600mg; 300mg - abacavir (abacavir sulfate) 600mg; lamivudine 300mg - nucleoside and nucleotide reverse transcriptase inhibitors

Canada - inglese - Health Canada

apotex inc - abacavir (abacavir sulfate); lamivudine - tablet - 600mg; 300mg - abacavir (abacavir sulfate) 600mg; lamivudine 300mg - nucleoside and nucleotide reverse transcriptase inhibitors

Australia - inglese - Department of Health (Therapeutic Goods Administration)

viiv healthcare pty ltd - abacavir sulfate, quantity: 702 mg (equivalent: abacavir, qty 600 mg); lamivudine, quantity: 300 mg; dolutegravir, quantity: 50 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; sodium starch glycollate; povidone; magnesium stearate; purified water; mannitol; titanium dioxide; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - triumeq is indicated for the treatment of human immunodeficiency virus (hiv) infection in adults and adolescents from 12 years of age who are antiretroviral treatment-na?ve or are infected with hiv without documented or clinically suspected resistance to any of the three antiretroviral agents (dolutegravir, abacavir or lamivudine) in triumeq.

Nuova Zelanda - inglese - Medsafe (Medicines Safety Authority)

rex medical ltd - abacavir sulfate 351.39mg equivalent to 300 mg abacavir - film coated tablet - 300 mg - active: abacavir sulfate 351.39mg equivalent to 300 mg abacavir excipient: colloidal silicon dioxide hypromellose magnesium stearate maize starch microcrystalline cellulose opadry yellow 15c52843 sodium starch glycolate - abacavir tablets are indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infection in adults and children.

Australia - inglese - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - lamivudine, quantity: 300 mg; abacavir sulfate, quantity: 702.78 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate; silicified microcrystalline cellulose; purified talc; crospovidone; titanium dioxide; hypromellose; polysorbate 80; macrogol 400 - abacavir/lamivudine viatris tablets are a combination of two nucleoside analogues (abacavir and lamivudine). abacavir/lamivudine viatris is indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infection in adults and adolescents from 12 years of age.

Belgio - inglese - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - abacavir hydrochloride 676,401 mg - eq. abacavir 600 mg; lamivudine 300 mg - film-coated tablet - 600 mg - 300 mg - abacavir hydrochloride 676.401 mg; lamivudine 300 mg - lamivudine and abacavir

Belgio - inglese - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

viatris gx bv-srl - abacavir hydrochloride 676,401 mg - eq. abacavir 600 mg; lamivudine 300 mg - film-coated tablet - 600 mg - 300 mg - abacavir hydrochloride 676.401 mg; lamivudine 300 mg - lamivudine and abacavir